All Drugs Associated with Second primary malignancy (Page 2)
237 drugs have been associated with Second primary malignancy in FAERS reports.
| Drug | Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|
| BEVACIZUMAB | 89 | 29 | 21 | 15 |
| ANASTROZOLE | 88 | 21 | 29 | 22 |
| BORTEZOMIB | 87 | 24 | 21 | 10 |
| OXALIPLATIN | 86 | 12 | 19 | 9 |
| PAZOPANIB | 81 | 16 | 22 | 10 |
| LEUCOVORIN | 80 | 30 | 8 | 9 |
| DACTINOMYCIN | 77 | 47 | 1 | 2 |
| TRAMETINIB DIMETHYL SULFOXIDE | 77 | 22 | 20 | 2 |
| CHLORAMBUCIL | 76 | 49 | 33 | 1 |
| CAPECITABINE | 75 | 14 | 7 | 7 |
| BINIMETINIB | 74 | 6 | 25 | 2 |
| IRINOTECAN | 70 | 12 | 10 | 3 |
| CRIZOTINIB | 68 | 9 | 13 | 2 |
| BUSULFAN | 65 | 21 | 19 | 6 |
| ZOMETA | 64 | 20 | 37 | 1 |
| MECHLORETHAMINE | 61 | 32 | 2 | 0 |
| OLAPARIB | 52 | 12 | 18 | 11 |
| ASPARAGINASE | 50 | 23 | 17 | 5 |
| BRENTUXIMAB VEDOTIN | 50 | 33 | 29 | 2 |
| PEMBROLIZUMAB | 47 | 5 | 22 | 9 |
| TRAMETINIB | 47 | 5 | 20 | 5 |
| ENZALUTAMIDE | 46 | 10 | 17 | 12 |
| HYDROXYUREA | 46 | 12 | 14 | 0 |
| LEUPROLIDE | 46 | 6 | 11 | 5 |
| THIOTEPA | 46 | 11 | 10 | 3 |
| NIVOLUMAB | 45 | 30 | 33 | 4 |
| AZACITIDINE | 44 | 36 | 29 | 2 |
| IBRUTINIB | 43 | 18 | 3 | 4 |
| METOPROLOL | 42 | 17 | 30 | 0 |
| AMLODIPINE | 39 | 6 | 22 | 1 |
| VINORELBINE | 39 | 6 | 3 | 4 |
| DASATINIB | 37 | 8 | 7 | 0 |
| LORLATINIB | 37 | 5 | 7 | 2 |
| TALAZOPARIB | 37 | 20 | 11 | 8 |
| TRETINOIN | 36 | 6 | 1 | 8 |
| THALIDOMIDE | 34 | 13 | 9 | 5 |
| OBINUTUZUMAB | 33 | 2 | 0 | 1 |
| OFATUMUMAB | 33 | 9 | 9 | 0 |
| FILGRASTIM | 32 | 23 | 3 | 4 |
| AREDIA | 31 | 7 | 20 | 0 |
| LOMUSTINE | 31 | 18 | 7 | 3 |
| METHYLPREDNISOLONE | 31 | 16 | 2 | 1 |
| ONDANSETRON | 30 | 12 | 22 | 5 |
| CARFILZOMIB | 29 | 14 | 7 | 4 |
| MORPHINE | 29 | 13 | 29 | 0 |
| PEMETREXED | 29 | 5 | 9 | 1 |
| UNSPECIFIED INGREDIENT | 29 | 6 | 10 | 0 |
| AXICABTAGENE CILOLEUCEL | 28 | 7 | 1 | 2 |
| CETUXIMAB | 27 | 2 | 7 | 0 |
| GLIVEC | 27 | 5 | 12 | 1 |